Abdominal conditions are common and can range from minor and self-limiting to life-threatening. As such, accurate and timely diagnosis is essential to ensure optimal patient outcomes. The Kehr's sign is a physical examination finding which was first described in 1901 and is thought to be a potential indicator of intra-abdominal pathology. In this article, we will explore the potential of Kehr's sign in diagnosing abdominal conditions.
Kehr's sign is a physical examination finding which is thought to be indicative of intra-abdominal pathology. It was first described by German physician, Dr. Karl Kehr in 1901. The sign is elicited by palpating the left lower quadrant of the abdomen and noting an abrupt shift in the sensation of pain when pressure is released. The pain is thought to be caused by an intra-abdominal mass which shifts when pressure is released. It has been suggested that the pain experienced is due to the mass pressing on the abdominal wall.
Kehr's sign has been associated with a variety of abdominal conditions, including appendicitis, ovarian torsion, diverticulitis, pancreatitis, and cholecystitis. It is also thought to be indicative of intra-abdominal malignancy, such as ovarian cancer.
Kehr's sign is typically diagnosed during a physical examination. The patient is asked to lie on their back and the abdomen is palpated. The physician will then press firmly on the left lower quadrant of the abdomen and note any changes in the sensation of pain when the pressure is released. If the patient experiences an abrupt shift in pain when the pressure is released, Kehr's sign is said to be present.
In addition to Kehr's sign, a variety of other tests are used in diagnosing abdominal conditions. These tests include imaging studies such as X-rays, CT scans, and ultrasounds. Blood tests may also be used to help diagnose abdominal conditions. Depending on the condition, a laparoscopy or laparotomy may be performed.
Kehr's sign is not considered to be a reliable indicator of intra-abdominal pathology. While it has been associated with a variety of abdominal conditions, its sensitivity and specificity are not well established. As such, it should not be relied upon as the sole indicator of an abdominal condition.
Kehr's sign is a physical examination finding which has been associated with a variety of abdominal conditions. While it is thought to be indicative of intra-abdominal pathology, its reliability is not well established. As such, it should not be relied upon as the sole indicator of an abdominal condition. Other tests, such as imaging studies, blood tests, and laparoscopy or laparotomy should also be used in diagnosing abdominal conditions.
1.
Taking Charge of Your Cancer Journey.
2.
Positive Trials; Malignancies Increasing in Younger Adults; Andre Braugher's Cancer Dx.
3.
Can Fasting Around Chemo Improve Ovarian Cancer Outcomes?
4.
Does Telenursing Improve QOL in Breast Cancer?
5.
Sevabertinib Approved for First-Line Mutated NSCLC
1.
The Pros and Cons of Using Cyclophosphamide in Cancer Treatment
2.
Predicting Incidental Prostate Cancer in BPH Surgery Patients
3.
Managing Acute Respiratory Failure in Hematological Malignancies
4.
AI in Genomics: Decoding the Human Genome for Cancer Treatment
5.
Modern Approaches to Detecting Residual Disease: Clinical Utility and Future Trends
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part III
2.
Treatment Sequencing Strategies in ALK + NSCLC Patients with CNS Diseases - Part II
3.
Targeting Oncologic Drivers with Dacomitinib: Further Discussion on Lung Cancer Treatment
4.
Future of Hematology
5.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part I
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation